Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Veriheal

DECEMBER 27, 2022

Let’s dive into what the research says about these promising new findings and how they might advance the field of psychedelic research. Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. The subjective nature of self-reported data can plague research.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Cannabis Law Report

AUGUST 18, 2022

The laboratory researched the fine print of every state’s rules for hemp sampling, THC potency, cannabinoid content, residual solvents, pesticides, mycotoxins, heavy metals, and microbiology. With that research, they created elaborate matrices to compare each mandate. Source: [link].

Compliance 52

Compliance Compliance Hemp Research and Development 52

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

JULY 23, 2021

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention.

Research and Development 105

Research and Development DEA Programs State Laws 105

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Canna Law Blog

AUGUST 7, 2023

Today, every time I research these new cannabinoids, I inevitably see ones I have never heard of before. If someone wants to put a new substance (say, a newly discovered/developed cannabinoid) into a dietary supplement), it will be considered an NDI. People constantly ask me how X cannabinoid will be regulated.

Cannabinoids 78

Cannabinoids Food DEA CBD 78

The Cannigma

JULY 3, 2023

The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. The DEA’s research quotas also include 384,460 grams of tetrahydrocannabinols, 40 grams of LSD, 50 grams of MDMA and 30 grams of psilocybin.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). if the plant is moved to Schedule III.

Research and Development 114

Research and Development DEA Marijuana Pharmaceutical 114

Otherside Farms

AUGUST 4, 2020

Concrete extraction technicians, researchers, marijuana cultivators, marketers, marijuana processors, cannabis branding, and developers will all have a place in the industry. The more thorough your business plan is (ie, the more data you have) the easier it’ll be to fund your dispensary. Research Your Competitors.

Business 52

Business Banking Dispensary Research and Development 52

SpeedWeed

MARCH 7, 2021

We also speak with Mark Diener, Senior Product Manager of JULABO USA , which manufactures liquid temperature control instrumentation for the cannabis and hemp industries as well as for research, science, laboratories, pilot plants, and industrial processes. Press the Play button below to listen to the podcast. ? That’s gotten huge.

Extraction 52

Extraction Data Hemp Research and Development 52

Canna Law Blog

NOVEMBER 6, 2021

Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Research was permitted in the mid-20th century, until the law stepped in.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

APRIL 14, 2022

Although research is still underway, the effects of both short- and long-term exposure to pesticides by consuming (i.e., pursuant to Drug Enforcement Agency (DEA) or state-level programs). by eating or smoking cannabis) are unknown. Next Steps.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. Research suggests that about one in five people will have an increase in paranoia as a result of the delta-9 THC after consuming cannabis. Every lab uses a different method so the data is not going to be consistent.”.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin founded MAPS as an official 501(c)(3) non-profit research organization on April 8, 1986. Later that year, Doblin sued the DEA for the first time.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country. hemp industry in the U.S.,

Vaping 105

Vaping Research and Development Data Business 105

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). This report (abstract below) asks if Epidiolex is as efficient a drug as the manufacturer believes it to be.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

AUGUST 16, 2019

” These NACB national advertising standards clearly establish how important it is “that the Cannabis industry develop a robust set of business-approved guidelines to build trust amongst market participants and local state and national regulators. In early August , J.

Marijuana 49

Marijuana Research and Development Seed-To-Sale Education 49

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. And time was an issue, since her research projects involved suicidal combat veterans with PTSD and stage 4 cancer patients who didn’t have long to live. Dr. Sue Sisley.

DEA 227

DEA Research and Development Clinical Trials Patients 227

SpeedWeed

DECEMBER 28, 2018

There’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval. Which Cannabis Strains Are Highest in CBD, According to Lab Data? RELATED STORY. No wonder GW has been working behind the scenes to lobby for a de-facto monopoly on legal CBD.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

SMPL

FEBRUARY 11, 2020

FDA is actively developing regulations for CBD since hemp and its derivatives were federally legalized under the 2018 Farm Bill. Another current rider that prohibits the Justice Department from contravening an industrial hemp research program was proposed to be removed. Department of Agriculture. View the full article here.

Research and Development 40

Research and Development Legalization Marijuana Programs 40

Cannabis Law Report

SEPTEMBER 19, 2019

As far as we know, Senate Majority Leader Mitch McConnell still isn’t willing to make even the slightest move toward legal weed; however, there have been some wicked, unforeseen developments. . Doctors say they look forward to seeing more research on the subject as more states allow marijuana in smokable form.

Vaping 55

Vaping Hemp Education Patients 55

Cannabis Law Report

JULY 30, 2019

Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Most reliable medical cannabis research filters into the U.S. Download : Cannabis Misinformation: What Does the DEA say about Marijuana?

Marijuana 45

Marijuana Patients Research and Development Programs 45